The Democratic Republic of Congo has launched clinical trials for two experimental treatments targeting Bundibugyo Ebola, a rare strain responsible for 1,460 confirmed cases and 452 deaths in the current outbreak. The PARTNERS study will test an antibody cocktail called MBP134, the antiviral remdesivir, and their combination – a critical move given there are currently […]